AIRE(redirected from Acute Infarction Ramipril/Reperfusion Efficacy Study)
Also found in: Dictionary, Thesaurus, Encyclopedia.
AIREAcute Infarction Ramipril/Reperfusion Efficacy study. A clinical trial that evaluated antihypertensive therapy with a long-acting ACE inhibitor, ramipril, on mortality and morbidity in patients with post-MI heart failure.
Conclusion All-cause mortality was significantly (27%) lower for ramipril patients than for placebo patients, if begun within 10 days of myocardial infarction-related heart failure.
AIRECardiology A clinical trial–The Acute Infarction Ramipril Efficacy Study that evaluated the effect of antihypertensive therapy with ramipril, a long-acting ACE inhibitor on M&M in Pts with post-MI heart failure. See ACE inhibitor, Acute myocardial infarction, Heart failure, Ramipril.
Patient discussion about AIRE
Q. Are superbugs contagious through the air? Last week we visited my dad in the hospital, and we noticed that on the next room’s door there was a warning sign. After asking, we were told it was a denoting that the patient inside had a superbug (called klebsiella). On our way out we passed against this patient in the hallway – is it possible that I also carry this superbag? Is it dangerous?
Q. breating air that has tetrachloroethene in it how does it affect you if u have prostate cancer the air in my building has been determined to have Tetrachloroethylene in it i have just been diagnosed with prostate cancer
here is a link to the abstract-
Q. where would i find list of all the "clean" cities and the rates of air pollution ...?